EDC for wearable device studies: clinical CRFs, ePRO, eConsent, and structured documentation for wearable endpoints with 21 CFR Part 11–aligned controls.
21 CFR Part 11 aligned · HIPAA-aligned security · No credit card required
One of the most valuable aspects of wearable device studies is the ability to combine objective physiological measurements with subjective patient reports. A heart rate variability (HRV) sensor provides objective autonomic nervous system data, but the participant’s concurrent report of stress, sleep quality, or symptom severity provides clinical context that transforms raw sensor data into meaningful health insights. Capture is designed for this complementary data collection. ePRO instruments collect participant-reported outcomes on the same timeline as wearable data collection, using the same platform and the same compliance infrastructure. Specialized templates like the HRV Companion log are purpose-built for studies that pair wearable measurements with subjective assessments. This integrated approach has practical benefits for analysis: clinical CRF data, ePRO data, and documented wearable endpoints export from a single dataset with consistent participant identifiers and timestamps. Analysts can merge objective and subjective measures without cross-system reconciliation, reducing data preparation time and the risk of linkage errors. For regulatory submissions, this combined dataset presents a coherent narrative: the wearable measurement provides the objective endpoint, the ePRO provides the patient’s perspective, and the clinical CRF documents the investigator’s assessment—all captured within a compliant framework with documented data provenance.
Wearable device studies require a data architecture that acknowledges the different characteristics of each data source. Raw wearable data—high-frequency, high-volume sensor readings—is best managed by the device vendor’s platform, which is optimized for signal processing, quality control, and biomarker derivation. Clinical CRF data and patient-reported ePRO data—structured, lower-volume, and directly interpretable—belong in a clinical-grade EDC with compliance controls. The connection between these systems is the derived endpoint: the wearable platform produces a clinical-grade summary measure (e.g., average daily step count, resting heart rate, sleep efficiency score), and this measure enters the EDC as a documented clinical endpoint alongside CRF and ePRO data. Capture’s CRF builder supports this architecture by allowing study teams to define structured endpoint forms specifically for wearable-derived measures. These forms can include the derived value, the measurement period, device compliance metrics (e.g., wear time percentage), and any quality flags. The data enters the same dataset as clinical and ePRO data and is subject to the same audit trail and access controls. This architecture is simpler and more maintainable than direct device-to-EDC integration for most wearable studies. It avoids the middleware layer, the real-time data streaming, and the custom development that add cost and complexity. And it correctly places the compliance burden on the clinical dataset while allowing the wearable platform to optimize for its strengths.
Wearable device studies collect data from participants in their daily environment—often continuously and passively. This raises consent considerations beyond traditional clinical trials: participants must understand what data the wearable collects, how often, whether collection is continuous or periodic, how data is processed, who has access, and how the data is linked to their clinical records. Capture’s eConsent module supports comprehensive informed consent for wearable studies. Consent forms can be structured with sections specific to wearable data collection: what the device measures, the data flow from device to study database, participant rights regarding device data, and procedures for device return or data deletion. Digital signatures document participant agreement with the same rigor as any clinical trial consent. For studies that use multiple data collection modalities—wearable, ePRO, and clinical visits—the consent document can address each modality while maintaining a single, integrated consent record in the audit trail. This is cleaner than managing separate consent documents for each data collection method. When protocols evolve—adding new wearable measures, changing collection frequency, or modifying data handling procedures—Capture’s consent versioning tracks the changes and documents which version each participant consented to. This audit trail is essential for IRB reporting and regulatory review of studies involving novel data collection technologies.
Overview
Wearable device studies use wearable sensors, patches, smartwatches, and other body-worn devices to collect continuous or periodic physiological data alongside traditional clinical endpoints and patient-reported outcomes. These studies are increasingly common across therapeutic areas: activity monitoring in musculoskeletal trials, heart rate variability in cardiology, sleep quality in neurology, glucose monitoring in metabolic disease, and step count or gait analysis in rehabilitation research. The EDC challenge for wearable studies is managing a multi-source dataset. Clinical site data (CRFs, lab results, clinician assessments) follows traditional EDC workflows. Patient-reported outcomes capture the participant’s subjective experience on their mobile device. And wearable data—often continuous, high-volume, and in device-specific formats—must be documented, referenced, or integrated into the overall study dataset. Capture provides EDC, eConsent, and ePRO in one platform with 21 CFR Part 11–aligned controls and HIPAA-aligned infrastructure. For wearable device studies, Capture handles the two data sources that most directly drive regulatory and clinical decisions: clinician-entered CRF data and patient-reported ePRO data. These share one platform, one audit trail, and one compliance framework. For the wearable data stream itself, Capture provides structured CRF templates that allow study teams to document device-derived endpoints, device compliance metrics, and summary measures alongside the clinical dataset. This approach reflects the practical reality of wearable device studies. The wearable data pipeline—raw sensor data, signal processing, feature extraction, and digital biomarker derivation—typically runs on the device manufacturer’s platform or a dedicated analytics pipeline. What the clinical study team needs in the EDC is the resulting clinical-grade summary: the derived biomarker value, the device compliance measurement, or the endpoint assessment that enters the statistical analysis alongside CRF and ePRO data. Capture provides the compliant framework for this clinical dataset.
Wearable device studies introduce complexity that traditional EDC platforms were not designed to handle. The core issue is data source heterogeneity: clinical visit data is structured and entered by trained coordinators, ePRO data is semi-structured and entered by participants, and wearable data is often continuous, automated, and in proprietary formats. Each data source has different collection cadences, quality characteristics, and compliance requirements. Enterprise EDC vendors increasingly market “wearable integration” capabilities, but these integrations often involve significant custom development, middleware layers, and per-study engineering costs. For many wearable studies—particularly pilot studies, investigator-initiated research, and early-phase programs—these integration costs are disproportionate to the study scope and budget. A more practical approach separates the wearable data pipeline from the clinical EDC while maintaining a unified view of the study dataset. The wearable device vendor handles raw data collection, processing, and biomarker derivation. The EDC captures clinical and ePRO data and provides structured fields for documenting wearable-derived endpoints. Both datasets are linked by participant identifiers and combined for analysis. Capture supports this practical approach. The integrated ePRO module captures patient-reported outcomes that often complement wearable data—subjective symptom reports alongside objective sensor measurements. The CRF builder creates structured forms for documenting device-derived endpoints. And the comprehensive audit trail and 21 CFR Part 11–aligned controls ensure that the clinical dataset meets regulatory standards regardless of how the wearable data was originally captured. Capture also offers specialized ePRO templates—such as HRV Companion logs—that are designed for studies where participants report subjective experiences alongside wearable-measured physiological data. These templates bridge the gap between objective device measurements and the participant’s lived experience.
FAQ
Explore the platform with a free sandbox. No sales call required.
Explore platform